华兴资本

INVESTMENT
MANAGEMENT

INVESTMENT BANKING

Since its inception, China Renaissance's Investment Banking segment has been focused on providing full life-cycle solutions to companies across the primary and secondary markets in mainland China, Hong Kong, the United States and Singapore. China Renaissance's strategy has evolved to align with China's latest development goals, market needs and industry trends, and has continued to enhance and strengthen its financial services capabilities to support the development of China's smart economy sector. To date, China Renaissance has partnered with more than 1,000 innovative smart economy companies in China across various sectors, including healthcare and life sciences, hard tech, emerging technologies, new energy, advanced manufacturing, industrial internet, smart enterprise services, as well as smart consumerism.

  • Financial Advisory
  • 私募融资:我们的私募融资业务帮助成长期的公司募集资金,服务范围包括发起及执行股权、债务及相关证券的私募融资。在提供私募融资服务时,我们会就资本架构提出意见并协助客户制定长期资本规划。

    并购顾问:我们向以中国为基地的新经济客户各种复杂的国内外并购交易提供咨询。我们的并购顾问服务帮助国内收购方接触优质的境外公司,连接国际机构投资者与境内优质新经济机遇。

    医疗顾问:我们的专业医疗顾问团队具有深厚的行业和金融交易经验,研究范围覆盖逾十个细分行业包括细胞治疗、基因学及生物医药,总数逾300家公司。

    Private Placement: Our private placement business assists growth-stage companies in raising private capital. Our services include the origination and execution of private placements in equity, debt and related securities. In addition, we will advise on capital structure and assist in long-term capital planning.

    M&A Advisory: We advise China-based clients operating new economy businesses on a wide range of complex domestic and cross-border M&A transactions. Our M&A advisory services facilitate access to quality onshore and offshore targets by domestic acquirers, and connect international institutional investors with onshore quality new economy opportunities.

    Healthcare Advisory: We have a dedicated healthcare advisory team with in-depth industry expertise and deal experience. We cover more than ten segments of the industry including cell therapy, genomics, and biological drugs, with an aggregate of more than 300 companies.

  • Securities Underwriting
  • 由于许多原有的顾问服务客户准备进入公开市场,我们于2012年开始提供承销服务。自此开始,我们成为备受信赖的首次公开发售顾问,以独立的角色为执行决策、把握市场时机、定价及分销等提供建议。

    We began offering underwriting services in 2012, as many of our advisory services clients prepared to access the public markets. Since then, we have become a trusted IPO advisor with an independent role advising on execution strategy, timing, pricing, and allocation.

  • Sales, Trading and Brokerage
  • 我们以代理人身份在二级市场协助全球国际机构客户包括资产管理人、对冲基金、家族办公室、保险公司及其他机构进行股票交易。此外,我们亦协助本公司的股票承销部门向国际机构客户分派所承销的股本证券。

    We execute equity trades as an agent in the secondary market for a range of international institutional clients, including asset managers, hedge funds, family offices, insurance companies, among others. In addition, we assist our equity underwriting services in the distribution of the equity securities.

  • Research
  • 我们的研究团队针对中国新经济公司的估值及研究分析,从行业及专题角度提出原创的投资观点。我们的团队涵盖多个和新经济关系密切的行业,包括互联网软件、电子商务、物流、线上娱乐、金融科技、技术、医疗、游戏、住宿及旅游。

    Our research team presents original investment ideas on China's new economy with company-specific valuations and research analyses as well as industry and thematic perspectives. Our team covers a broad range of new economy focused sectors, including internet software, e-commerce, logistics, online entertainment, fintech, technology, healthcare, gaming, lodging, and tourism.

WEALTH
MANAGEMENT

CR SECURITIES

©2023 China Renaissance All Right Reserved. Beijing ICP No. 06028429-1.

京公网安备 11010502036122号